Elon Musk’s brain chip fails test approval

The US Food and Drug Administration refused to give approval to conduct a test on the digital brain chip developed by the “Neuralink” company owned by US billionaire Elon Musk.
And according to what was reported by the Reuters news agency, the American organization identified dozens of potential problems that the “Neuralink” company must address before testing the chip on humans, the most important of which is the issue of the danger of the lithium battery to brain tissue, in addition to the fine wires used and the possibility of causing infections and its impact on brain functions, as well as The effect of high temperature of the slide and the extent to which it can be removed from the brain without causing any damage.
Musk had announced at the end of last year that his company intends to test the device on the human brain during the current year 2023, and that the project aims to help people who suffer from paralysis, help them control computers and mobile phones, and treat other neurological disorders in the brain and spinal cord.